TRACON Pharmaceuticals Highlights Updated Envafolimab Clinical Results in MSI-H/dMMR Colorectal CancerGlobeNewsWire • 09/21/20
TRACON Pharmaceuticals to Present at the H.C. Wainwright 22nd Annual Global Investment ConferenceGlobeNewsWire • 09/10/20
TRACON Pharmaceuticals' (TCON) CEO Charles Theuer on Q2 2020 Results - Earnings Call TranscriptSeeking Alpha • 08/06/20
TRACON to Report Second Quarter 2020 Financial Results and Company Highlights on August 5, 2020GlobeNewsWire • 07/29/20
TRACON Pharmaceuticals Announces Filing of Protocol for ENVASARC Pivotal Trial with the FDAGlobeNewsWire • 07/16/20
TRACON Pharmaceuticals to Host Key Opinion Leader Webinar on Envafolimab for the Treatment of SarcomaGlobeNewsWire • 07/13/20
TRACON Pharmaceuticals Highlights Updated Envafolimab Results in MSI-H/dMMR Colorectal Cancer and Results from Clinical Trial of Opdivo and Yervoy Combination Therapy in Undifferentiated Pleomorphic Sarcoma Conducted by Alliance for Clinical Trials in OncGlobeNewsWire • 05/29/20
TRACON Pharmaceuticals (TCON) CEO Charles Theuer on Q1 2020 Results - Earnings Call TranscriptSeeking Alpha • 05/14/20
TRACON Pharmaceuticals Reports First Quarter 2020 Financial Results and Provides Corporate UpdateGlobeNewsWire • 05/13/20
TRACON Pharmaceuticals Announces Successful Type B Meeting with FDA for Pivotal Study of Envafolimab in SarcomaGlobeNewsWire • 05/11/20
TRACON Pharmaceuticals Retains Global Rights to TRC253 Following Completion of a Phase 1/2 TrialGlobeNewsWire • 04/24/20
TRACON Pharmaceuticals Announces Appointment of Biotechnology Industry Veteran Shahe Garabedian as Senior Vice President of Quality Assurance and Granting of Inducement AwardGlobeNewsWire • 04/14/20
TRACON Pharmaceuticals Announces Appointment of Saundra Pelletier to Board of DirectorsGlobeNewsWire • 03/19/20
TRACON Announces Submission of Request for Type B Meeting with FDA to Discuss Trial Design for ENVASARC: A Potential Pivotal Study of Envafolimab in SarcomaGlobeNewsWire • 03/16/20
Santen and TRACON Discontinue Development of DE-122 for Wet Age-Related Macular DegenerationGlobeNewsWire • 03/09/20
TRACON Pharmaceuticals Inc. (TCON) CEO Charles Theuer on Q4 2019 Results - Earnings Call TranscriptSeeking Alpha • 02/28/20
TRACON Pharmaceuticals, 3D Medicines and Jiangsu Alphamab Announce Partnership for Development of Subcutaneous PD-L1 Single-Domain Antibody in Soft Tissue SarcomaGlobeNewsWire • 12/20/19
TRACON Pharmaceuticals' (TCON) CEO Charles Theuer on Q3 2019 Results - Earnings Call TranscriptSeeking Alpha • 11/06/19
TRACON Pharmaceuticals Announces $15 Million Common Stock Purchase Agreement with Aspire Capital Fund, LLCGlobeNewsWire • 10/21/19
TRACON Pharmaceuticals to Present at the Rodman & Renshaw 21st Annual Global Investment Conference Sponsored by H.C. WainwrightGlobeNewsWire • 09/03/19